nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNC1—nerve—acquired immunodeficiency syndrome	0.0114	0.0235	CbGeAlD
Dalfampridine—KCNV2—retina—acquired immunodeficiency syndrome	0.00697	0.0143	CbGeAlD
Dalfampridine—KCNA1—nerve—acquired immunodeficiency syndrome	0.00682	0.014	CbGeAlD
Dalfampridine—KCNA10—lung—acquired immunodeficiency syndrome	0.00605	0.0124	CbGeAlD
Dalfampridine—KCNA10—nervous system—acquired immunodeficiency syndrome	0.0056	0.0115	CbGeAlD
Dalfampridine—KCNH4—nervous system—acquired immunodeficiency syndrome	0.00499	0.0103	CbGeAlD
Dalfampridine—KCNG4—nervous system—acquired immunodeficiency syndrome	0.00499	0.0103	CbGeAlD
Dalfampridine—KCNB2—nervous system—acquired immunodeficiency syndrome	0.00499	0.0103	CbGeAlD
Dalfampridine—KCNB2—central nervous system—acquired immunodeficiency syndrome	0.00481	0.00987	CbGeAlD
Dalfampridine—KCNH4—central nervous system—acquired immunodeficiency syndrome	0.00481	0.00987	CbGeAlD
Dalfampridine—KCNG4—central nervous system—acquired immunodeficiency syndrome	0.00481	0.00987	CbGeAlD
Dalfampridine—KCNQ4—retina—acquired immunodeficiency syndrome	0.00474	0.00973	CbGeAlD
Dalfampridine—KCNG3—lymphoid tissue—acquired immunodeficiency syndrome	0.00473	0.0097	CbGeAlD
Dalfampridine—KCNQ5—retina—acquired immunodeficiency syndrome	0.00461	0.00946	CbGeAlD
Dalfampridine—KCNH5—nervous system—acquired immunodeficiency syndrome	0.00457	0.00938	CbGeAlD
Dalfampridine—KCNG3—blood—acquired immunodeficiency syndrome	0.00445	0.00913	CbGeAlD
Dalfampridine—KCNH5—central nervous system—acquired immunodeficiency syndrome	0.0044	0.00903	CbGeAlD
Dalfampridine—KCNG2—brain—acquired immunodeficiency syndrome	0.00428	0.00879	CbGeAlD
Dalfampridine—KCNS2—nervous system—acquired immunodeficiency syndrome	0.00425	0.00872	CbGeAlD
Dalfampridine—KCNA6—nervous system—acquired immunodeficiency syndrome	0.00425	0.00872	CbGeAlD
Dalfampridine—KCNA6—central nervous system—acquired immunodeficiency syndrome	0.00409	0.00839	CbGeAlD
Dalfampridine—KCNS2—central nervous system—acquired immunodeficiency syndrome	0.00409	0.00839	CbGeAlD
Dalfampridine—KCNV1—nervous system—acquired immunodeficiency syndrome	0.00399	0.0082	CbGeAlD
Dalfampridine—KCNH3—blood—acquired immunodeficiency syndrome	0.00396	0.00814	CbGeAlD
Dalfampridine—KCNA3—lymphoid tissue—acquired immunodeficiency syndrome	0.00385	0.00791	CbGeAlD
Dalfampridine—KCNV1—central nervous system—acquired immunodeficiency syndrome	0.00384	0.00789	CbGeAlD
Dalfampridine—KCNH8—blood—acquired immunodeficiency syndrome	0.00384	0.00788	CbGeAlD
Dalfampridine—KCNH3—spinal cord—acquired immunodeficiency syndrome	0.00382	0.00784	CbGeAlD
Dalfampridine—KCNG4—brain—acquired immunodeficiency syndrome	0.00382	0.00784	CbGeAlD
Dalfampridine—KCNB2—brain—acquired immunodeficiency syndrome	0.00382	0.00784	CbGeAlD
Dalfampridine—KCNH4—brain—acquired immunodeficiency syndrome	0.00382	0.00784	CbGeAlD
Dalfampridine—KCNA3—digestive system—acquired immunodeficiency syndrome	0.00381	0.00781	CbGeAlD
Dalfampridine—KCNV2—nervous system—acquired immunodeficiency syndrome	0.00379	0.00777	CbGeAlD
Dalfampridine—KCNA5—retina—acquired immunodeficiency syndrome	0.00378	0.00775	CbGeAlD
Dalfampridine—KCNH8—spinal cord—acquired immunodeficiency syndrome	0.0037	0.00759	CbGeAlD
Dalfampridine—KCNG1—vagina—acquired immunodeficiency syndrome	0.00367	0.00754	CbGeAlD
Dalfampridine—KCNV2—central nervous system—acquired immunodeficiency syndrome	0.00364	0.00748	CbGeAlD
Dalfampridine—KCNA3—blood—acquired immunodeficiency syndrome	0.00363	0.00744	CbGeAlD
Dalfampridine—KCNH1—nervous system—acquired immunodeficiency syndrome	0.00361	0.00741	CbGeAlD
Dalfampridine—KCNG3—nervous system—acquired immunodeficiency syndrome	0.00361	0.00741	CbGeAlD
Dalfampridine—KCNC2—nervous system—acquired immunodeficiency syndrome	0.00361	0.00741	CbGeAlD
Dalfampridine—KCNA3—spinal cord—acquired immunodeficiency syndrome	0.00349	0.00717	CbGeAlD
Dalfampridine—KCNH5—brain—acquired immunodeficiency syndrome	0.00349	0.00717	CbGeAlD
Dalfampridine—KCNG3—central nervous system—acquired immunodeficiency syndrome	0.00348	0.00714	CbGeAlD
Dalfampridine—KCNC2—central nervous system—acquired immunodeficiency syndrome	0.00348	0.00714	CbGeAlD
Dalfampridine—KCNH1—central nervous system—acquired immunodeficiency syndrome	0.00348	0.00714	CbGeAlD
Dalfampridine—KCNS1—blood—acquired immunodeficiency syndrome	0.00345	0.00708	CbGeAlD
Dalfampridine—KCNA2—blood—acquired immunodeficiency syndrome	0.00345	0.00708	CbGeAlD
Dalfampridine—KCNA2—spinal cord—acquired immunodeficiency syndrome	0.00332	0.00682	CbGeAlD
Dalfampridine—KCND1—blood—acquired immunodeficiency syndrome	0.0033	0.00677	CbGeAlD
Dalfampridine—KCNS3—skin of body—acquired immunodeficiency syndrome	0.00325	0.00667	CbGeAlD
Dalfampridine—KCNS2—brain—acquired immunodeficiency syndrome	0.00325	0.00666	CbGeAlD
Dalfampridine—KCNA6—brain—acquired immunodeficiency syndrome	0.00325	0.00666	CbGeAlD
Dalfampridine—KCNG1—nervous system—acquired immunodeficiency syndrome	0.00322	0.00661	CbGeAlD
Dalfampridine—KCNH3—nervous system—acquired immunodeficiency syndrome	0.00322	0.00661	CbGeAlD
Dalfampridine—KCNS1—vagina—acquired immunodeficiency syndrome	0.0032	0.00656	CbGeAlD
Dalfampridine—KCNA3—lung—acquired immunodeficiency syndrome	0.00318	0.00653	CbGeAlD
Dalfampridine—KCNH8—nervous system—acquired immunodeficiency syndrome	0.00312	0.0064	CbGeAlD
Dalfampridine—KCNB1—nervous system—acquired immunodeficiency syndrome	0.00312	0.0064	CbGeAlD
Dalfampridine—KCNG1—central nervous system—acquired immunodeficiency syndrome	0.0031	0.00636	CbGeAlD
Dalfampridine—KCNH3—central nervous system—acquired immunodeficiency syndrome	0.0031	0.00636	CbGeAlD
Dalfampridine—KCND1—vagina—acquired immunodeficiency syndrome	0.00306	0.00628	CbGeAlD
Dalfampridine—KCNC1—spinal cord—acquired immunodeficiency syndrome	0.00305	0.00627	CbGeAlD
Dalfampridine—KCNV1—brain—acquired immunodeficiency syndrome	0.00305	0.00626	CbGeAlD
Dalfampridine—KCNC3—nervous system—acquired immunodeficiency syndrome	0.00303	0.00621	CbGeAlD
Dalfampridine—KCNB1—central nervous system—acquired immunodeficiency syndrome	0.003	0.00616	CbGeAlD
Dalfampridine—KCNH8—central nervous system—acquired immunodeficiency syndrome	0.003	0.00616	CbGeAlD
Dalfampridine—KCNA4—nervous system—acquired immunodeficiency syndrome	0.00294	0.00604	CbGeAlD
Dalfampridine—KCNA3—nervous system—acquired immunodeficiency syndrome	0.00294	0.00604	CbGeAlD
Dalfampridine—KCNC3—central nervous system—acquired immunodeficiency syndrome	0.00291	0.00598	CbGeAlD
Dalfampridine—KCNV2—brain—acquired immunodeficiency syndrome	0.00289	0.00594	CbGeAlD
Dalfampridine—KCNC4—lung—acquired immunodeficiency syndrome	0.00289	0.00594	CbGeAlD
Dalfampridine—KCND1—lung—acquired immunodeficiency syndrome	0.00289	0.00594	CbGeAlD
Dalfampridine—KCNQ5—vagina—acquired immunodeficiency syndrome	0.00286	0.00587	CbGeAlD
Dalfampridine—KCNA4—central nervous system—acquired immunodeficiency syndrome	0.00283	0.00582	CbGeAlD
Dalfampridine—KCNA3—central nervous system—acquired immunodeficiency syndrome	0.00283	0.00582	CbGeAlD
Dalfampridine—KCNF1—blood—acquired immunodeficiency syndrome	0.00282	0.0058	CbGeAlD
Dalfampridine—KCNA1—retina—acquired immunodeficiency syndrome	0.00282	0.0058	CbGeAlD
Dalfampridine—KCNS1—nervous system—acquired immunodeficiency syndrome	0.0028	0.00575	CbGeAlD
Dalfampridine—KCNA2—nervous system—acquired immunodeficiency syndrome	0.0028	0.00575	CbGeAlD
Dalfampridine—KCNG3—brain—acquired immunodeficiency syndrome	0.00276	0.00567	CbGeAlD
Dalfampridine—KCNC2—brain—acquired immunodeficiency syndrome	0.00276	0.00567	CbGeAlD
Dalfampridine—KCNH1—brain—acquired immunodeficiency syndrome	0.00276	0.00567	CbGeAlD
Dalfampridine—KCNF1—spinal cord—acquired immunodeficiency syndrome	0.00272	0.00559	CbGeAlD
Dalfampridine—KCNA2—central nervous system—acquired immunodeficiency syndrome	0.0027	0.00553	CbGeAlD
Dalfampridine—KCNS1—central nervous system—acquired immunodeficiency syndrome	0.0027	0.00553	CbGeAlD
Dalfampridine—KCNC4—nervous system—acquired immunodeficiency syndrome	0.00268	0.0055	CbGeAlD
Dalfampridine—KCND1—nervous system—acquired immunodeficiency syndrome	0.00268	0.0055	CbGeAlD
Dalfampridine—KCNA5—digestive system—acquired immunodeficiency syndrome	0.00265	0.00544	CbGeAlD
Dalfampridine—KCNF1—vagina—acquired immunodeficiency syndrome	0.00262	0.00538	CbGeAlD
Dalfampridine—KCNC4—central nervous system—acquired immunodeficiency syndrome	0.00258	0.00529	CbGeAlD
Dalfampridine—KCND1—central nervous system—acquired immunodeficiency syndrome	0.00258	0.00529	CbGeAlD
Dalfampridine—KCNH7—nervous system—acquired immunodeficiency syndrome	0.00257	0.00528	CbGeAlD
Dalfampridine—KCNC1—nervous system—acquired immunodeficiency syndrome	0.00257	0.00528	CbGeAlD
Dalfampridine—KCNQ5—nervous system—acquired immunodeficiency syndrome	0.0025	0.00514	CbGeAlD
Dalfampridine—KCNH7—central nervous system—acquired immunodeficiency syndrome	0.00248	0.00509	CbGeAlD
Dalfampridine—KCNC1—central nervous system—acquired immunodeficiency syndrome	0.00248	0.00509	CbGeAlD
Dalfampridine—KCNF1—lung—acquired immunodeficiency syndrome	0.00248	0.00508	CbGeAlD
Dalfampridine—KCNH3—brain—acquired immunodeficiency syndrome	0.00246	0.00505	CbGeAlD
Dalfampridine—KCNG1—brain—acquired immunodeficiency syndrome	0.00246	0.00505	CbGeAlD
Dalfampridine—KCNA5—spinal cord—acquired immunodeficiency syndrome	0.00243	0.005	CbGeAlD
Dalfampridine—KCNQ5—central nervous system—acquired immunodeficiency syndrome	0.00241	0.00495	CbGeAlD
Dalfampridine—KCNS3—spinal cord—acquired immunodeficiency syndrome	0.00238	0.00489	CbGeAlD
Dalfampridine—KCNB1—brain—acquired immunodeficiency syndrome	0.00238	0.00489	CbGeAlD
Dalfampridine—KCNH8—brain—acquired immunodeficiency syndrome	0.00238	0.00489	CbGeAlD
Dalfampridine—KCNA5—vagina—acquired immunodeficiency syndrome	0.00234	0.00481	CbGeAlD
Dalfampridine—KCNC3—brain—acquired immunodeficiency syndrome	0.00231	0.00475	CbGeAlD
Dalfampridine—KCNS3—vagina—acquired immunodeficiency syndrome	0.00229	0.00471	CbGeAlD
Dalfampridine—KCNF1—nervous system—acquired immunodeficiency syndrome	0.00229	0.00471	CbGeAlD
Dalfampridine—KCNA4—brain—acquired immunodeficiency syndrome	0.00225	0.00462	CbGeAlD
Dalfampridine—KCNA3—brain—acquired immunodeficiency syndrome	0.00225	0.00462	CbGeAlD
Dalfampridine—KCNA5—lung—acquired immunodeficiency syndrome	0.00222	0.00455	CbGeAlD
Dalfampridine—KCNF1—central nervous system—acquired immunodeficiency syndrome	0.00221	0.00453	CbGeAlD
Dalfampridine—KCNA3—lymph node—acquired immunodeficiency syndrome	0.00217	0.00446	CbGeAlD
Dalfampridine—KCNS3—lung—acquired immunodeficiency syndrome	0.00217	0.00445	CbGeAlD
Dalfampridine—KCNQ3—lung—acquired immunodeficiency syndrome	0.00217	0.00445	CbGeAlD
Dalfampridine—KCNS1—brain—acquired immunodeficiency syndrome	0.00214	0.00439	CbGeAlD
Dalfampridine—KCNA2—brain—acquired immunodeficiency syndrome	0.00214	0.00439	CbGeAlD
Dalfampridine—KCND2—spinal cord—acquired immunodeficiency syndrome	0.00208	0.00426	CbGeAlD
Dalfampridine—KCNA2—lymph node—acquired immunodeficiency syndrome	0.00207	0.00424	CbGeAlD
Dalfampridine—KCNA5—nervous system—acquired immunodeficiency syndrome	0.00205	0.00421	CbGeAlD
Dalfampridine—KCNC4—brain—acquired immunodeficiency syndrome	0.00205	0.0042	CbGeAlD
Dalfampridine—KCND1—brain—acquired immunodeficiency syndrome	0.00205	0.0042	CbGeAlD
Dalfampridine—KCNQ3—nervous system—acquired immunodeficiency syndrome	0.00201	0.00412	CbGeAlD
Dalfampridine—KCNH6—lung—acquired immunodeficiency syndrome	0.00198	0.00406	CbGeAlD
Dalfampridine—KCNC4—lymph node—acquired immunodeficiency syndrome	0.00198	0.00406	CbGeAlD
Dalfampridine—KCNA5—central nervous system—acquired immunodeficiency syndrome	0.00197	0.00405	CbGeAlD
Dalfampridine—KCNH7—brain—acquired immunodeficiency syndrome	0.00197	0.00404	CbGeAlD
Dalfampridine—KCNQ4—brain—acquired immunodeficiency syndrome	0.00197	0.00404	CbGeAlD
Dalfampridine—KCNC1—brain—acquired immunodeficiency syndrome	0.00197	0.00404	CbGeAlD
Dalfampridine—KCNQ3—central nervous system—acquired immunodeficiency syndrome	0.00193	0.00397	CbGeAlD
Dalfampridine—KCNQ5—brain—acquired immunodeficiency syndrome	0.00191	0.00393	CbGeAlD
Dalfampridine—KCNQ1—digestive system—acquired immunodeficiency syndrome	0.00191	0.00392	CbGeAlD
Dalfampridine—KCNQ5—lymph node—acquired immunodeficiency syndrome	0.00185	0.00379	CbGeAlD
Dalfampridine—KCNQ2—nervous system—acquired immunodeficiency syndrome	0.00185	0.00379	CbGeAlD
Dalfampridine—KCNH6—nervous system—acquired immunodeficiency syndrome	0.00183	0.00376	CbGeAlD
Dalfampridine—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.00182	0.00355	CcSEcCtD
Dalfampridine—KCNA1—spinal cord—acquired immunodeficiency syndrome	0.00182	0.00374	CbGeAlD
Dalfampridine—KCNQ1—blood—acquired immunodeficiency syndrome	0.00182	0.00374	CbGeAlD
Dalfampridine—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.00182	0.00354	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00181	0.00354	CcSEcCtD
Dalfampridine—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.00181	0.00354	CcSEcCtD
Dalfampridine—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.00181	0.00353	CcSEcCtD
Dalfampridine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.0018	0.00351	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.0018	0.00351	CcSEcCtD
Dalfampridine—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.0018	0.0035	CcSEcCtD
Dalfampridine—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.00178	0.00348	CcSEcCtD
Dalfampridine—KCNQ2—central nervous system—acquired immunodeficiency syndrome	0.00178	0.00365	CbGeAlD
Dalfampridine—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00178	0.00347	CcSEcCtD
Dalfampridine—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.00177	0.00346	CcSEcCtD
Dalfampridine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00177	0.00345	CcSEcCtD
Dalfampridine—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.00177	0.00345	CcSEcCtD
Dalfampridine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.00177	0.00344	CcSEcCtD
Dalfampridine—KCNH6—central nervous system—acquired immunodeficiency syndrome	0.00177	0.00362	CbGeAlD
Dalfampridine—KCNQ1—bone marrow—acquired immunodeficiency syndrome	0.00176	0.00362	CbGeAlD
Dalfampridine—KCNF1—brain—acquired immunodeficiency syndrome	0.00175	0.0036	CbGeAlD
Dalfampridine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00175	0.00342	CcSEcCtD
Dalfampridine—KCND2—nervous system—acquired immunodeficiency syndrome	0.00175	0.00359	CbGeAlD
Dalfampridine—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.00175	0.0034	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00175	0.0034	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00174	0.00339	CcSEcCtD
Dalfampridine—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.00174	0.00339	CcSEcCtD
Dalfampridine—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00173	0.00338	CcSEcCtD
Dalfampridine—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.00173	0.00337	CcSEcCtD
Dalfampridine—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00173	0.00337	CcSEcCtD
Dalfampridine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00172	0.00336	CcSEcCtD
Dalfampridine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00172	0.00336	CcSEcCtD
Dalfampridine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00172	0.00335	CcSEcCtD
Dalfampridine—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00172	0.00335	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00171	0.00334	CcSEcCtD
Dalfampridine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00171	0.00334	CcSEcCtD
Dalfampridine—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.0017	0.00332	CcSEcCtD
Dalfampridine—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.0017	0.00331	CcSEcCtD
Dalfampridine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00169	0.0033	CcSEcCtD
Dalfampridine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.00169	0.0033	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00169	0.00329	CcSEcCtD
Dalfampridine—KCND2—central nervous system—acquired immunodeficiency syndrome	0.00169	0.00346	CbGeAlD
Dalfampridine—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.00168	0.00327	CcSEcCtD
Dalfampridine—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00167	0.00326	CcSEcCtD
Dalfampridine—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00167	0.00325	CcSEcCtD
Dalfampridine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00167	0.00325	CcSEcCtD
Dalfampridine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00167	0.00325	CcSEcCtD
Dalfampridine—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00166	0.00324	CcSEcCtD
Dalfampridine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00166	0.00323	CcSEcCtD
Dalfampridine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00165	0.00322	CcSEcCtD
Dalfampridine—KCND3—lung—acquired immunodeficiency syndrome	0.00165	0.00338	CbGeAlD
Dalfampridine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00164	0.00319	CcSEcCtD
Dalfampridine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00163	0.00319	CcSEcCtD
Dalfampridine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00163	0.00318	CcSEcCtD
Dalfampridine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00162	0.00316	CcSEcCtD
Dalfampridine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.00162	0.00315	CcSEcCtD
Dalfampridine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.00161	0.00315	CcSEcCtD
Dalfampridine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00161	0.00313	CcSEcCtD
Dalfampridine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00161	0.00313	CcSEcCtD
Dalfampridine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00161	0.00313	CcSEcCtD
Dalfampridine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.0016	0.00313	CcSEcCtD
Dalfampridine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.0016	0.00312	CcSEcCtD
Dalfampridine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.0016	0.00312	CcSEcCtD
Dalfampridine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.0016	0.00312	CcSEcCtD
Dalfampridine—KCNQ1—lung—acquired immunodeficiency syndrome	0.0016	0.00328	CbGeAlD
Dalfampridine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.0016	0.00311	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00159	0.00311	CcSEcCtD
Dalfampridine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00159	0.0031	CcSEcCtD
Dalfampridine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00159	0.00309	CcSEcCtD
Dalfampridine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00158	0.00309	CcSEcCtD
Dalfampridine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00158	0.00309	CcSEcCtD
Dalfampridine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00158	0.00308	CcSEcCtD
Dalfampridine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00157	0.00307	CcSEcCtD
Dalfampridine—KCNA5—brain—acquired immunodeficiency syndrome	0.00157	0.00322	CbGeAlD
Dalfampridine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00156	0.00305	CcSEcCtD
Dalfampridine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00156	0.00305	CcSEcCtD
Dalfampridine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00155	0.00303	CcSEcCtD
Dalfampridine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00155	0.00303	CcSEcCtD
Dalfampridine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00154	0.00301	CcSEcCtD
Dalfampridine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00154	0.003	CcSEcCtD
Dalfampridine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00154	0.003	CcSEcCtD
Dalfampridine—KCNS3—brain—acquired immunodeficiency syndrome	0.00154	0.00315	CbGeAlD
Dalfampridine—KCNQ3—brain—acquired immunodeficiency syndrome	0.00154	0.00315	CbGeAlD
Dalfampridine—KCNA1—nervous system—acquired immunodeficiency syndrome	0.00153	0.00315	CbGeAlD
Dalfampridine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00153	0.00299	CcSEcCtD
Dalfampridine—KCND3—nervous system—acquired immunodeficiency syndrome	0.00153	0.00313	CbGeAlD
Dalfampridine—KCNA5—lymph node—acquired immunodeficiency syndrome	0.00152	0.00311	CbGeAlD
Dalfampridine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00151	0.00295	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00151	0.00295	CcSEcCtD
Dalfampridine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00151	0.00294	CcSEcCtD
Dalfampridine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.0015	0.00293	CcSEcCtD
Dalfampridine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.0015	0.00292	CcSEcCtD
Dalfampridine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.0015	0.00292	CcSEcCtD
Dalfampridine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.0015	0.00292	CcSEcCtD
Dalfampridine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00149	0.0029	CcSEcCtD
Dalfampridine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00149	0.0029	CcSEcCtD
Dalfampridine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00148	0.0029	CcSEcCtD
Dalfampridine—KCNS3—lymph node—acquired immunodeficiency syndrome	0.00148	0.00305	CbGeAlD
Dalfampridine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00289	CcSEcCtD
Dalfampridine—KCNA1—central nervous system—acquired immunodeficiency syndrome	0.00148	0.00303	CbGeAlD
Dalfampridine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00148	0.00288	CcSEcCtD
Dalfampridine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00147	0.00287	CcSEcCtD
Dalfampridine—KCND3—central nervous system—acquired immunodeficiency syndrome	0.00147	0.00302	CbGeAlD
Dalfampridine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00146	0.00285	CcSEcCtD
Dalfampridine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00146	0.00285	CcSEcCtD
Dalfampridine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00146	0.00285	CcSEcCtD
Dalfampridine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00146	0.00285	CcSEcCtD
Dalfampridine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00146	0.00285	CcSEcCtD
Dalfampridine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00146	0.003	CbGeAlD
Dalfampridine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00145	0.00284	CcSEcCtD
Dalfampridine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00145	0.00283	CcSEcCtD
Dalfampridine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00145	0.00283	CcSEcCtD
Dalfampridine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00145	0.00282	CcSEcCtD
Dalfampridine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00145	0.00282	CcSEcCtD
Dalfampridine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00144	0.00281	CcSEcCtD
Dalfampridine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00144	0.0028	CcSEcCtD
Dalfampridine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00143	0.0028	CcSEcCtD
Dalfampridine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00143	0.00279	CcSEcCtD
Dalfampridine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00142	0.00278	CcSEcCtD
Dalfampridine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.00277	CcSEcCtD
Dalfampridine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.00276	CcSEcCtD
Dalfampridine—KCNQ2—brain—acquired immunodeficiency syndrome	0.00141	0.0029	CbGeAlD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00141	0.00275	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00141	0.00274	CcSEcCtD
Dalfampridine—KCNH6—brain—acquired immunodeficiency syndrome	0.0014	0.00288	CbGeAlD
Dalfampridine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.0014	0.00273	CcSEcCtD
Dalfampridine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00139	0.00272	CcSEcCtD
Dalfampridine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00139	0.00271	CcSEcCtD
Dalfampridine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00139	0.00271	CcSEcCtD
Dalfampridine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00139	0.00271	CcSEcCtD
Dalfampridine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00138	0.0027	CcSEcCtD
Dalfampridine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00138	0.00269	CcSEcCtD
Dalfampridine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00138	0.00268	CcSEcCtD
Dalfampridine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00137	0.00268	CcSEcCtD
Dalfampridine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00137	0.00268	CcSEcCtD
Dalfampridine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00267	CcSEcCtD
Dalfampridine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00136	0.00266	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00136	0.00265	CcSEcCtD
Dalfampridine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00136	0.00264	CcSEcCtD
Dalfampridine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00134	0.00262	CcSEcCtD
Dalfampridine—KCND2—brain—acquired immunodeficiency syndrome	0.00134	0.00275	CbGeAlD
Dalfampridine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00134	0.00261	CcSEcCtD
Dalfampridine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00134	0.0026	CcSEcCtD
Dalfampridine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00133	0.0026	CcSEcCtD
Dalfampridine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00133	0.0026	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00133	0.00259	CcSEcCtD
Dalfampridine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00133	0.00259	CcSEcCtD
Dalfampridine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00133	0.00259	CcSEcCtD
Dalfampridine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00132	0.00258	CcSEcCtD
Dalfampridine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00132	0.00258	CcSEcCtD
Dalfampridine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.00258	CcSEcCtD
Dalfampridine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00132	0.00257	CcSEcCtD
Dalfampridine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00132	0.00257	CcSEcCtD
Dalfampridine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00132	0.00256	CcSEcCtD
Dalfampridine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00131	0.00256	CcSEcCtD
Dalfampridine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00131	0.00256	CcSEcCtD
Dalfampridine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00131	0.00255	CcSEcCtD
Dalfampridine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.00254	CcSEcCtD
Dalfampridine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.0013	0.00254	CcSEcCtD
Dalfampridine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.00253	CcSEcCtD
Dalfampridine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.0013	0.00253	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.00253	CcSEcCtD
Dalfampridine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00129	0.00252	CcSEcCtD
Dalfampridine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00129	0.00251	CcSEcCtD
Dalfampridine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00129	0.00251	CcSEcCtD
Dalfampridine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00128	0.0025	CcSEcCtD
Dalfampridine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00127	0.00249	CcSEcCtD
Dalfampridine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00127	0.00248	CcSEcCtD
Dalfampridine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00127	0.00248	CcSEcCtD
Dalfampridine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00127	0.00248	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00127	0.00248	CcSEcCtD
Dalfampridine—Rash—Stavudine—acquired immunodeficiency syndrome	0.00127	0.00248	CcSEcCtD
Dalfampridine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00127	0.00248	CcSEcCtD
Dalfampridine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00127	0.00247	CcSEcCtD
Dalfampridine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00127	0.00247	CcSEcCtD
Dalfampridine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00126	0.00246	CcSEcCtD
Dalfampridine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00126	0.00246	CcSEcCtD
Dalfampridine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00126	0.00246	CcSEcCtD
Dalfampridine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00126	0.00246	CcSEcCtD
Dalfampridine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00126	0.00245	CcSEcCtD
Dalfampridine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00125	0.00244	CcSEcCtD
Dalfampridine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00125	0.00244	CcSEcCtD
Dalfampridine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00125	0.00244	CcSEcCtD
Dalfampridine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00124	0.00243	CcSEcCtD
Dalfampridine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00124	0.00242	CcSEcCtD
Dalfampridine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00124	0.00242	CcSEcCtD
Dalfampridine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00123	0.0024	CcSEcCtD
Dalfampridine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00123	0.00239	CcSEcCtD
Dalfampridine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.00239	CcSEcCtD
Dalfampridine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00122	0.00238	CcSEcCtD
Dalfampridine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00122	0.00238	CcSEcCtD
Dalfampridine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00121	0.00237	CcSEcCtD
Dalfampridine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00121	0.00237	CcSEcCtD
Dalfampridine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00237	CcSEcCtD
Dalfampridine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.0012	0.00234	CcSEcCtD
Dalfampridine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.0012	0.00234	CcSEcCtD
Dalfampridine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.0012	0.00234	CcSEcCtD
Dalfampridine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.0012	0.00233	CcSEcCtD
Dalfampridine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00231	CcSEcCtD
Dalfampridine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00118	0.0023	CcSEcCtD
Dalfampridine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00118	0.0023	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.00229	CcSEcCtD
Dalfampridine—KCNA1—brain—acquired immunodeficiency syndrome	0.00117	0.00241	CbGeAlD
Dalfampridine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00117	0.00228	CcSEcCtD
Dalfampridine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00117	0.00228	CcSEcCtD
Dalfampridine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00117	0.00228	CcSEcCtD
Dalfampridine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00117	0.00228	CcSEcCtD
Dalfampridine—KCND3—brain—acquired immunodeficiency syndrome	0.00117	0.00239	CbGeAlD
Dalfampridine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00116	0.00227	CcSEcCtD
Dalfampridine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00116	0.00226	CcSEcCtD
Dalfampridine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.00225	CcSEcCtD
Dalfampridine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00221	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00113	0.00221	CcSEcCtD
Dalfampridine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00113	0.00221	CcSEcCtD
Dalfampridine—KCNQ1—brain—acquired immunodeficiency syndrome	0.00113	0.00232	CbGeAlD
Dalfampridine—KCND3—lymph node—acquired immunodeficiency syndrome	0.00113	0.00231	CbGeAlD
Dalfampridine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00112	0.00219	CcSEcCtD
Dalfampridine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00219	CcSEcCtD
Dalfampridine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00112	0.00219	CcSEcCtD
Dalfampridine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.00217	CcSEcCtD
Dalfampridine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00111	0.00217	CcSEcCtD
Dalfampridine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.0011	0.00215	CcSEcCtD
Dalfampridine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.0011	0.00215	CcSEcCtD
Dalfampridine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.0011	0.00215	CcSEcCtD
Dalfampridine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00215	CcSEcCtD
Dalfampridine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.0011	0.00214	CcSEcCtD
Dalfampridine—KCNQ1—lymph node—acquired immunodeficiency syndrome	0.00109	0.00224	CbGeAlD
Dalfampridine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00109	0.00212	CcSEcCtD
Dalfampridine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.00211	CcSEcCtD
Dalfampridine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00108	0.00211	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00108	0.00211	CcSEcCtD
Dalfampridine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00108	0.0021	CcSEcCtD
Dalfampridine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00107	0.00209	CcSEcCtD
Dalfampridine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00206	CcSEcCtD
Dalfampridine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00203	CcSEcCtD
Dalfampridine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00104	0.00203	CcSEcCtD
Dalfampridine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00104	0.00202	CcSEcCtD
Dalfampridine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00201	CcSEcCtD
Dalfampridine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00103	0.002	CcSEcCtD
Dalfampridine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00103	0.002	CcSEcCtD
Dalfampridine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00102	0.00199	CcSEcCtD
Dalfampridine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00102	0.00198	CcSEcCtD
Dalfampridine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.001	0.00196	CcSEcCtD
Dalfampridine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000993	0.00194	CcSEcCtD
Dalfampridine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000979	0.00191	CcSEcCtD
Dalfampridine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000977	0.00191	CcSEcCtD
Dalfampridine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000974	0.0019	CcSEcCtD
Dalfampridine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000971	0.00189	CcSEcCtD
Dalfampridine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00097	0.00189	CcSEcCtD
Dalfampridine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000968	0.00189	CcSEcCtD
Dalfampridine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000966	0.00188	CcSEcCtD
Dalfampridine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000964	0.00188	CcSEcCtD
Dalfampridine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000941	0.00183	CcSEcCtD
Dalfampridine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000936	0.00183	CcSEcCtD
Dalfampridine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000929	0.00181	CcSEcCtD
Dalfampridine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000928	0.00181	CcSEcCtD
Dalfampridine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000923	0.0018	CcSEcCtD
Dalfampridine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000921	0.0018	CcSEcCtD
Dalfampridine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000914	0.00178	CcSEcCtD
Dalfampridine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000901	0.00176	CcSEcCtD
Dalfampridine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000897	0.00175	CcSEcCtD
Dalfampridine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000875	0.00171	CcSEcCtD
Dalfampridine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000867	0.00169	CcSEcCtD
Dalfampridine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000866	0.00169	CcSEcCtD
Dalfampridine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000859	0.00167	CcSEcCtD
Dalfampridine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000858	0.00167	CcSEcCtD
Dalfampridine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000853	0.00166	CcSEcCtD
Dalfampridine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000833	0.00163	CcSEcCtD
Dalfampridine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000827	0.00161	CcSEcCtD
Dalfampridine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000827	0.00161	CcSEcCtD
Dalfampridine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000826	0.00161	CcSEcCtD
Dalfampridine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000821	0.0016	CcSEcCtD
Dalfampridine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000809	0.00158	CcSEcCtD
Dalfampridine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000795	0.00155	CcSEcCtD
Dalfampridine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000789	0.00154	CcSEcCtD
Dalfampridine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000788	0.00154	CcSEcCtD
Dalfampridine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000783	0.00153	CcSEcCtD
Dalfampridine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000779	0.00152	CcSEcCtD
Dalfampridine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000743	0.00145	CcSEcCtD
Dalfampridine—KCNH2—blood—acquired immunodeficiency syndrome	0.000694	0.00142	CbGeAlD
Dalfampridine—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.000672	0.00138	CbGeAlD
Dalfampridine—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.000669	0.00137	CbGeAlD
Dalfampridine—KCNH2—vagina—acquired immunodeficiency syndrome	0.000643	0.00132	CbGeAlD
Dalfampridine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000568	0.00117	CbGeAlD
Dalfampridine—KCNH2—nervous system—acquired immunodeficiency syndrome	0.000563	0.00116	CbGeAlD
Dalfampridine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000561	0.00115	CbGeAlD
Dalfampridine—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.000542	0.00111	CbGeAlD
Dalfampridine—CYP2E1—blood—acquired immunodeficiency syndrome	0.000535	0.0011	CbGeAlD
Dalfampridine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000515	0.00106	CbGeAlD
Dalfampridine—CYP2E1—lung—acquired immunodeficiency syndrome	0.000469	0.000962	CbGeAlD
Dalfampridine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000434	0.000891	CbGeAlD
Dalfampridine—KCNH2—brain—acquired immunodeficiency syndrome	0.000431	0.000884	CbGeAlD
Dalfampridine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000418	0.000858	CbGeAlD
Dalfampridine—KCNH2—lymph node—acquired immunodeficiency syndrome	0.000416	0.000854	CbGeAlD
Dalfampridine—CYP2E1—brain—acquired immunodeficiency syndrome	0.000332	0.000681	CbGeAlD
